Intravenous Transplantation of Human Hair Follicle-Derived Mesenchymal Stem Cells Ameliorates Trabecular Bone Loss in Osteoporotic Mice
March 2022
in “
Frontiers in Cell and Developmental Biology
”
TLDR Human hair follicle stem cells can help treat bone loss in osteoporosis.
The study demonstrated that intravenous transplantation of human hair follicle-derived mesenchymal stem cells (hHF-MSCs) ameliorated trabecular bone loss in osteoporotic mice by promoting bone formation and inhibiting bone resorption. The research involved 12 mice per group and showed that hHF-MSCs up-regulated OPG and Wnt2b while down-regulating VCAM-1, RANKL, and Noggin, which are key regulators in bone metabolism. This suggested a novel therapeutic potential for hHF-MSCs in treating osteoporosis, offering a promising alternative to other mesenchymal stem cells due to their accessibility and potential for long-term storage and use. However, further studies were needed to understand the detailed mechanisms and long-term effects of this treatment.